Recurring concern
Inadequate controls on the sale and online access to highly toxic substances
First reported 27 Nov 2013•Latest report 9 Jul 2025
What this concern includes
Includes failures of controls specifically intended to regulate, restrict, monitor or provide safeguards around the retail or online sale and purchase of highly toxic or potentially fatal substances, including inadequate regulated-poison controls, unrestricted quantities and absent internet-sale protections.
Not included
- Excludes ordinary medication, prescription-only medicine and controlled-drug supply concerns where the shared issue is medication regulation rather than access to highly toxic substances.
- Excludes hazards involving toxic substances where no deficiency in sale, purchase, access or regulatory control is identified.
- Excludes product-safety, labelling or consumer-information failures that do not concern controlling access to highly toxic or potentially fatal substances.
- Excludes generic regulatory gaps unrelated to the sale or online access of toxic substances.
- Reports
- 16
- Individual concerns
- 22
- Date range
- 2013–2025
- Stated actions
- 36
Distinct published reports
A report can raise multiple concerns
First to latest report issue date
Described in published responses
Reports over time
Reports over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Concerns and responses across reports
Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.
-
Concerns raised1
Unrestricted internet availability of dinitrophenol
This report raised 2 other concerns. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
-
Concerns raised1
Uncontrolled internet availability of research chemicals
This report raised 1 other concern. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.3
-
Action
Introduce the Psychoactive Substances Bill to establish a blanket ban on supplying psychoactive substances for human consumption.
Stated by Home Office -
Action
Work with internet providers to ensure compliance with laws governing online drug advertising and sales.
Stated by Home Office -
Action
Develop international partnerships and regulatory cooperation to address overseas websites trading controlled drugs and emerging supply threats.
Stated by Home Office
-
Concerns raised1
Availability of potent and toxic acetylfentanyl through legal marketing and the internet
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
-
Concerns raised1
Lack of controls on individual helium canister purchase quantities
This report raised 2 other concerns. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.1
-
Position
Evidence that even small amounts of helium can cause death means controls on availability would be ineffective.
Stated by Department of Health and Social Care
-
Concerns raised2
Lack of regulation of the sale of large amounts of toxic or potentially fatal gases
Lack of Trading Standards powers to take action or prosecute
This report raised 1 other concern. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.2
-
Action
Work with the Department of Health to support restrictions on inappropriate access to volatile substances.
Stated by Public Health England -
Action
Work with the Department of Health to support efforts to restrict inappropriate access to volatile substances.
Stated by Public Health England
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.4
-
Position
The private professional body has no powers to become involved in this matter.
Stated by Chartered Trading Standards Institute
-
Position
Responsibility for this matter rests with trading standards departments run by local authorities.
Stated by Chartered Trading Standards Institute -
Position
Trading Standards lacks powers to act against retailers selling these products, except where sales to children constitute an offence.
Stated by Oldham Borough Council -
Position
Legislative action to regulate these products is a matter for the Department for Business, Innovation and Skills to consider.
Stated by Oldham Borough Council
-
Concerns raised1
Unrestricted availability of AMT through the internet and community
This report raised 1 other concern. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
Data last updated 7 September 2026